UNSPSC 85444701: The diagnosis of glucocorticoids and synthetic analogues

In this classification, this covers the group of activities that yields a diagnosis of glucocorticoids and synthetic analogues. Glucocorticoids and synthetic analogues is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y42.0.

UNSPSC 85444701 Diagnosis of glucocorticoids and synthetic analogues is a Commodity code that shows a fundamental mismatch between its nominal scope and recent state and local procurement activity. The code's name references pharmaceutical diagnostic testing for steroid compounds; however, the three most recent opportunities tagged under this code involve diagnostic imaging systems (PACS implementation at a county hospital), special education contracted services (speech therapy, occupational therapy, audiology), and temporary health professional staffing (radiologists, therapists, audiologists, and other clinical personnel). None of these opportunities align with glucocorticoid or synthetic steroid diagnostics. The mismatch suggests either systematic miscoding by issuing bodies or a legacy taxonomy assignment that no longer reflects procurement intent.

The opportunities that are present span a county health system (San Mateo County), an independent school district (Birdville ISD in northeast Texas), and another county health system (Santa Clara County), posted between July and October 2026. The San Mateo Medical Center PACS solicitation (IFB, due October 21, 2026) seeks enterprise diagnostic imaging infrastructure; Birdville ISD's special education services RFP (due October 21, 2026) requests audiologists, speech therapists, and related specialists across 30 campuses; and Santa Clara Health System's staffing RFQ (due October 7, 2026) establishes a qualified vendor pool for temporary diagnostic imaging, audiology, and therapy professionals. Geographic activity is limited to California (San Mateo and Santa Clara Counties) and Texas (Tarrant County). The code shows no recent activity aligned with its stated pharmaceutical diagnostic scope and does not warrant pursuit for glucocorticoid testing-related work.